Skechers Performance Partners for a Second Year with American Cancer Society to Support the Fight against Breast Cancer

Skechers Performance releases a footwear and performance apparel
collection, in conjunction with a marketing campaign to promote breast
cancer awareness month.

MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Skechers Performance, a division of SKECHERS USA, Inc. (NYSE:SKX), is
thrilled to announce its 2015 partnership with the American Cancer
Society to help in the fight to end breast cancer. For the second year
in a row, Skechers Performance will launch a month-long marketing
program that includes in-store, digital and print executions, as well as
the sponsorship of the American Cancer Society Making Strides Against
Breast Cancer® walk in San Francisco. To commemorate the partnership,
Skechers Performance is releasing a limited edition “Resistance”
footwear collection marked with the iconic breast cancer awareness pink
ribbon and a limited-edition performance apparel line which will be
available in SKECHERS retail stores and online late September 2015.

“We are proud to partner with American Cancer Society and help their
cause in the fight against breast cancer,” said Michael Greenberg,
president, SKECHERS USA. “After seeing the success from last year’s
campaign, we wanted to continue our support for a second year, and to
help build awareness about all the incredible work that American Cancer
Society does with their Making Strides initiative.”

“We are grateful for this continued partnership with Skechers
Performance Division, and look forward to the impact this will have in
raising awareness and revenue as we continue to make a difference in the
fight to end breast cancer,” said Daniela Campari, senior vice
president, integrated revenue and marketing, American Cancer Society.
“Collaborations like this are critical to moving our mission forward and
we thank Skechers for their commitment in helping us save lives.”

The Skechers Performance “Resistance” footwear collection includes the
Skechers GOrun 4, GOrun Ride 4, GOwalk 3, GOwalk 2 Flash and a boat shoe
from Skechers on-the-GO. The 2015 designs incorporate a black, white and
charcoal color pallet with the classic pink hue weaved in. Each style
also features the pink ribbon detailing on the heel. The performance
apparel includes everything you need to get active, with items including
the Endurance Seamless Tank, Never Stop Legging, Keep Going Sports Bra
and the Hopeful Jacket to name a few. The line is available at SKECHERS
retail stores, and at select SKECHERS retail partners
through October.

SKECHERS will also launch a register round-up program in participating
domestic SKECHERS retail stores to offer customers the opportunity to
support the American Cancer by allowing customers to round up their
purchase of any item(s) made to the nearest whole dollar to benefit the
Making Strides initiative. For the first time, SKECHERS will also launch
the register round-up program on e-commerce, allowing customers to
similarly round up their final purchase at check out on
The program will launch in stores and online October 1st and run through
October 31st.

Finally, Skechers Performance Division is sponsoring the 2015 American
Cancer Society Making Strides Against Breast Cancer walk in San
Francisco on Saturday, October 24, 2015, at Hellman Hollow Park.

The funds raised for American Cancer Society will support breast cancer
research, help provide free information and services, and assist women
in need to access mammograms.

To learn more about the American Cancer Society and their fight against
breast cancer visit
or call 800.227.2345.

Learn more about Skechers Performance at
and follow us on Facebook (, Twitter
( and Instagram

For more information and/or images, please contact Jolene Abbott at
310.318.3100 x4839 or

About the American Cancer Society
American Cancer Society is a global grassroots force of 2.5 million
volunteers saving lives and fighting for every birthday threatened by
every cancer in every community. As the largest voluntary health
organization, the Society’s efforts have contributed to a 20 percent
decline in cancer death rates in the U.S. since 1991, and a 50 percent
drop in smoking rates. Thanks in part to our progress, more than 14
million Americans who have had cancer and countless more who have
avoided it will celebrate more birthdays this year. We are determined to
finish the fight against cancer. We’re finding cures as the
nation’s largest private, not-for-profit investor in cancer research,
ensuring people facing cancer have the help they need and continuing the
fight for access to quality health care, lifesaving screenings, clean
air, and more. For more information, to get help, or to join the fight,
call us anytime, day or night, at 1-800-227-2345 or visit

USA, Inc., based in Manhattan Beach, California, designs, develops and
markets a diverse range of lifestyle footwear for men, women and
children, as well as performance footwear for men and women. Skechers
footwear is available in the United States and over 120 countries and
territories worldwide via department and specialty stores, more than
1,050 Skechers retail stores, and Skechers’ e-commerce website. Skechers
manages its international business through a network of global
distributors, joint venture partners in Asia, and 12 wholly-owned
subsidiaries in Brazil, Canada, Chile, Japan and throughout Europe. For
more information, please visit
and follow us on Facebook (
and Twitter (

This announcement contains forward-looking statements that are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include,
without limitation, Skechers’ future growth, financial results and
operations, its development of new products, future demand for its
products and growth opportunities, its planned opening of new stores,
advertising and marketing initiatives, and the expansion plans for
Skechers’ European Distribution Center. Forward-looking statements can
be identified by the use of forward looking language such as “believe,”
“anticipate,” “expect,” “estimate,” “intend,” “plan,” “project,” “will
be,” “will continue,” “will result,” “could,” “may,” “might,” or any
variations of such words with similar meanings. Any such statements are
subject to risks and uncertainties that could cause actual results to
differ materially from those projected in forward-looking statements.
Factors that might cause or contribute to such differences include
international economic, political and market conditions including the
uncertainty of sustained recovery in Europe; entry into the highly
competitive performance footwear market; sustaining, managing and
forecasting costs and proper inventory levels; losing any significant
customers; decreased demand by industry retailers and cancellation of
order commitments due to the lack of popularity of particular designs
and/or categories of products; maintaining brand image and intense
competition among sellers of footwear for consumers; anticipating,
identifying, interpreting or forecasting changes in fashion trends,
consumer demand for the products and the various market factors
described above; sales levels during the spring, back-to-school and
holiday selling seasons; and other factors referenced or incorporated by
reference in Skechers’ annual report on Form 10-K for the year ended
December 31, 2014 and its quarterly report on Form 10-Q for the three
months ended June 30, 2015. The risks included here are not exhaustive.
Skechers operates in a very competitive and rapidly changing
environment. New risks emerge from time to time and the companies cannot
predict all such risk factors, nor can the companies assess the impact
of all such risk factors on their respective businesses or the extent to
which any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. Given these risks and uncertainties, you should not place
undue reliance on forward-looking statements as a prediction of actual
results. Moreover, reported results should not be considered an
indication of future performance.


Jolene Abbott, 310-318-3100 x4839